CD40LG and COVID-19: To characterize COVID-19 humoral immune responses, we collected blood samples from COVID-19-recovered subjects and assayed for the presence of specific IgM and IgG antibodies in plasma (1:100 diluted) by ELISA Kits, which use SARS-CoV-2-S1 RBD as a capture antigen.